| # | Drug | Count |
|---|---|---|
| 0 | BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE | 137 |
| 1 | BUPRENORPHINE | 40 |
| 2 | DUPILUMAB | 30 |
| 3 | GABAPENTIN | 24 |
| 4 | BUDESONIDE | 23 |
| 5 | CLOZAPINE | 23 |
| 6 | ACETAMINOPHEN | 22 |
| 7 | ASPIRIN | 17 |
| 8 | ASPIRIN 325 MG | 17 |
| 9 | ASPIRIN 81 MG | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE | 137 | 0.0056 |
| 1 | ODEVIXIBAT | 1 | 0.0025 |
| 2 | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | 4 | 0.0017 |
| 3 | TESTOSTERONE ENANTHATE | 2 | 0.0012 |
| 4 | RILONACEPT | 1 | 0.0009 |
| 5 | BUPRENORPHINE AND NALOXONE | 1 | 0.0008 |
| 6 | MITAPIVAT | 1 | 0.0008 |
| 7 | STANDARDIZED SENNA CONCENTRATE | 9 | 0.0007 |
| 8 | METHYLNALTREXONE BROMIDE | 1 | 0.0007 |
| 9 | PHENTERMINE AND TOPIRAMATE | 4 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 57 |
| 1 | Partial Opioid Agonist [EPC] | 41 |
| 2 | Atypical Antipsychotic [EPC] | 38 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 35 |
| 4 | Benzodiazepine [EPC] | 30 |
| 5 | Interleukin-4 Receptor alpha Antagonist [EPC] | 30 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 19 |
| 7 | Opioid Agonist [EPC] | 17 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 17 |
| 9 | Anti-epileptic Agent [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Ileal Bile Acid Transporter Inhibitor [EPC] | 1 | 0.0022 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 3 | Pyruvate Kinase Activator [EPC] | 1 | 0.0008 |
| 4 | Aryl Hydrocarbon Receptor Agonist [EPC] | 1 | 0.0005 |
| 5 | Partial Opioid Agonist [EPC] | 41 | 0.0004 |
| 6 | Provitamin D2 Compound [EPC] | 12 | 0.0004 |
| 7 | Monobactam Antibacterial [EPC] | 1 | 0.0004 |
| 8 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 9 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |